Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgery No Better Than Exercise for Chronic Knee Pain

By HospiMedica staff writers
Posted on 26 Dec 2007
A new study indicates that in patients suffering from chronic patellofemoral syndrome (PFPS)--a chronic pain in the front part of the knee--arthroscopic surgery combined with exercise is no better than exercise alone in alleviating pain. More...


Researchers at the ORTON Research Institute (Helsinki, Finland) conducted a randomized controlled trial to study the efficacy of arthroscopy (compared with exercise) in 56 patients with chronic PFPS. The patients were randomly divided into two groups; the first group was treated with knee arthroscopy and an eight-week home exercise program and the second group was treated with the exercise program only. The researchers assessed the patients after nine months using the Kujala score for knee pain and mobility. They also estimated the direct healthcare costs per patient.

The researchers found that patients in both groups experienced reduced pain and showed marked improvement in knee mobility, with no significant difference in the average Kujala score between the two groups. Other tests also revealed that the improvements for patients treated with surgery and exercise were almost exactly the same as for the exercise-only patients. However, the average cost of treatment was higher per patient who underwent both arthroscopy and exercise therapy. The researchers also carried out a second follow up at two years and still found no differences in outcome between the two patient groups. They concluded that arthroscopy is not a cost effective treatment for chronic PFPS and that surgery should not be routinely used to treat the condition. The study was published on December 13, 2007, in the online open access journal BioMedCentral (BMC) Medicine.

"Whilst chronic knee pain is a common complaint, there is a lack of evidence that arthroscopic surgery has a better outcome than other forms of treatment including therapeutic exercise,” concluded lead author Jyrki Kettunen, P.T, Ph.D., and colleagues. "Giving these patients a therapeutic exercise regime rather than putting them through surgery could save money.”

Patellofemoral pain syndrome is often treated with arthroscopic surgery, in which equipment inserted through small incisions in the knee is used to both diagnose the cause of the problem and attempt to fix it.


Related Links:
ORTON Research Institute

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.